Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures

Journal of Neuroimmunology

Volumn 85, Issue 1, 1998, Pages 1-10

  Jeohn, Gwang Ho ^a   Kong, Ling Yuan ^a   Wilson, Belinda ^a   Hudson, Pearlie ^a   Hong, Jau Shyong ^a  

^a Neuropharmacology Section   (United States)

Author keywords

Cytokine; Glia; Lipopolysaccharide; Neurons; Neurotoxicity; Nitric oxide

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIA CELL; IMMUNOPATHOGENESIS; MOUSE; NERVE CELL CULTURE; NERVE CELL LESION; NEUROIMMUNOLOGY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COCULTURE TECHNIQUES; CYTOKINES; DRUG COMBINATIONS; DRUG SYNERGISM; ENZYME INHIBITORS; INTERFERON TYPE II; INTERLEUKIN-1; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED STRAINS; NEUROGLIA; NEURONS; NEUROTOXINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032077890     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00204-X     Document Type: Article

References (40)

1. Boje K.M., Arora P.K. Microglia-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:1992;250-256.
2. Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc. Natl. Acad. Sci. USA. 86:1989;9030-9033.
3. Chao C.C., Hu S., Molitor T.W., Shaskan E.G., Peterson P.K. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:1992;2736-2741.
4. Chao C.C., Molitor T.W., Hu S. Neuroprotective role of IL-4 against activated microglia. J. Immunol. 151:1993;1473-1481.
5. Chao C.C., Hu S., Peterson P.K. Glia, cytokines, and neurotoxicity. Crit. Rev. Neurobiol. 9:1995;189-205.
6. Dawson V.L., Dawson T.M. Nitric oxide actions in neurochemistry. Neurochem. Int. 29:1996;97-110.
7. Dawson T.M., Snyder S.H. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain. J. Neurosci. 14:1994;5147-5149.
8. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
9. Dawson T.M., Steiner J.P., Dawson V.L., Dinerman J.L., Uhl G.R., Snyder S.H. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci. USA. 90:1993;9808-9812.
10. Dawson V.L., Dawson T.M., Bartley D.A., Uhl G.R., Snyder S.H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
11. Dawson V.L., Brahmbhatt H.P., Mong J.A., Dawson T.M. Expression of inducible nitric oxide synthase causes delayed neurotoxicity in primary mixed neuronal-glial cortical cultures. Neuropharmacology. 33:1994;1425-1430.
12. Dawson V.L., Kizushi V.M., Huang P.L., Snyder S.H., Dawson T.M. Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J. Neurosci. 16:1996;2479-2487.
13. Dickson D.W., Mattiace L.A., Kure K., Hutchins K., Lyman W.D., Brosnan C.F. Microglia in human disease, with an emphasis on acquired immune deficiency syndrome. Lab. Invest. 64:1991;135-156.
14. Epstein L.G., Gendelman H.E. Human immunodeficiency virus type 1 infection of the nervous system: Pathogenetic mechanisms. Ann. Neurol. 33:1993;429-436.
15. Galea E., Feinstein D.L., Reis D.J. Induction of calcium-dependent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA. 89:1992;10945-10949.
16. Garthwaite J., Garthwaite G., Palmer R.M.J., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. Mol. Pharmacol. Sect. 172:1989;413-416.
17. Gomez-Pinilla F., Cummings B.J., Cotman C.W. Induction of basic fibroblast growth factor in Alzheimer's disease pathology. NeuroReport. 1:1990;211-214.
18. 15N ]nitrate in biological fluids Anal. Biochem. 126:1982;131-138.
19. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L. III, Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
20. Hewett S.J., Csernansky C.A., Choi D.W. Selective potentiation of NMDA-induced neuronal injury following induction of astrocytic iNOS. Neuron. 13:1994;487-494.
21. Koh J.Y., Choi D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods. 20:1987;83-90.
22. Kong L.-Y., McMillian M.K., Maronport R., Hong J.-S. Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res. 729:1996;102-109.
23. Kong L.-Y., Lai C., Wilson B.C., Simpson J.N., Hong J.-S. Protein tyrosine kinase inhibitors lipopolysaccharide-induced proinflammatory cytokine production in mixed glia, microglia-enriched or astrocyte-enriched cultures. Neurochem. Int. 30:1997;491-497.
24. Lee S.C., Liu W., Dickson D.W., Brosnan C.F., Berman J.W. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1β J. Immunol. 150:1993;2659-2667.
25. Lipton S.A. Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists. Dev. Neurosci. 16:1994;145-151.
26. Matsumoto Y., Ohmori K., Fujiwara M. Microglial and astroglial reactions to inflammatory lesions of experimental autoimmune encephalomyelitis in the rat central nervous system. J. Neuroimmunol. 37:1992;23-33.
27. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
28. McGeer P.L., McGeer E.G., Kawamata T., Yamada T., Akiyama H. Reactions of the immune system in chronic degenerative neurological diseases. Can. J. Neurol. Sci. 18:1991;376-379.
29. McMillian M.K., Mullis S.B., Wu G.C., Hudson P.M., Pennypacker K.R., Hong J.S. Regulation of tyrosine hydroxylase in olfactory bulb cultures: Selective inhibition of depolarization-induced increase by endogenous opioids. Brain Res. 658:1994;105-111.
30. Meda L., Cassatella M.A., Szendrei G.I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ Nature. 374:1995;647-650.
31. Merrill J.E., Chen I.S.Y. HIV-1, macrophages, glial cells, and cytokines in AIDS nervous system disease. FASEB J. 5:1991;2391-2397.
32. Merrill J.E., Kono D.H., Clayton J., Ando D.G., Hinton D.R., Hofman F.M. Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice. Proc. Natl. Acad. Sci. USA. 89:1992;574-578.
33. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease. Neurobiol. Aging. 9:1988;339-349.
34. Rothwell N.J., Relton J.K. Involvement of cytokines in acute neurodegeneration in the CNS. Neurosci. Biobehav. Rev. 17:1993;217-227.
35. Simmons M.L., Murphy S. Induction of nitric oxide synthase in glial cells. J. Neurochem. 59:1992;897-905.
36. Spencer D.C., Price R.W. Human immunodeficiency virus and the central nervous system. Annu. Rev. Microbiol. 46:1992;655-693.
37. Traugott U., Lebon P. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J. Neurol. Sci. 84:1988;257-264.
38. Tunkel A.R., Wispelwey B., Scheld W.M. Bacterial meningitis: Recent advances in pathophysiology and treatment. Ann. Intern. Med. 112:1990;610-623.
39. Tyor W.R., Glass D.J., Griffin J.W., Becker P.S., McArthur J.C., Bezman L., Griffin D.E. Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 31:1992;349-360.
40. van der Wal E.A., Gomez-Pinilla F., Cotman C.W. Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. NeuroReport. 4:1993;69-72.